SKP2 overexpression in mouse prostates induces atypical cell proliferation, leading to a progressive development of spontaneous prostatic lesions including hyperplasia, mPIN, and low-grade prostatic adenocarcinoma over 14 months of age. Here, SKP2 is linked to prostate adenocarcinoma.